ClearPoint Neuro Inc’s recently made public that its Director TIMOTHY RICHARDS acquired Company’s shares for reported $0.13 million on Jun 10 ’25. In the deal valued at $13.28 per share,10,000 shares were bought.
Then, JOSEPH M BURNETT TRUST bought 21,247 shares, generating $282,358 in total proceeds.
Before that, FALLON LYNNETTE C sold 10,200 shares. ClearPoint Neuro Inc shares valued at $128,226 were divested by the Director at a price of $12.57 per share. As a result of the transaction, FALLON LYNNETTE C now holds 40,901 shares, worth roughly $0.54 million.
A number of analysts have revised their coverage, including Stifel’s analysts, who began to cover the stock in late October with a ‘”a Buy”‘ rating.
Price Performance Review of CLPT
On Tuesday, ClearPoint Neuro Inc [NASDAQ:CLPT] saw its stock fall -0.15% to $13.29. Over the last five days, the stock has gained 4.98%. ClearPoint Neuro Inc shares have fallen nearly -13.59% since the year began. Nevertheless, the stocks have risen 131.53% over the past one year.
How much short interest is there in ClearPoint Neuro Inc?
A steep rise in short interest was recorded in ClearPoint Neuro Inc stocks on 2025-05-15, growing by 0.31 million shares to a total of 1.21 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-15 was 0.9 million shares. There was a rise of 25.61%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on March 18, 2021 when Lake Street began covering the stock and recommended ‘”a Buy”‘ rating along with a $32 price target.
